By Adriano Marchese
Enovis said Wednesday that its chief executive officer, Matt Trerotola, is set to retire and will step down from the role after the company finds a successor.
The medical technology said it has begun to work with an executive search firm to identify a new industry leader.
Once the company finds a candidate to succeed in the CEO role, Enovis and Trerotola will enter into a retirement and transition agreement whereby Trerotola will continue to serve as an employee and executive advisor for a one-year period to help with a smooth transition of responsibilities.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
February 26, 2025 06:15 ET (11:15 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。